Jim Cramer Gives His Opinion On Bristol-Myers Squibb, Moderna And More

On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes Moderna Inc MRNA. He thinks that its technology is good and he believes it's going to be hard pressed to be independent.

Cramer is concerned about Nielsen Holdings plc NLSN. He explained that it has a 5 percent yield, but its business is very tentative.

Realty Income Corp O is on fire and it benefits from the decline in the interest that you get for treasuries, said Cramer.

Bristol-Myers Squibb Co BMY stock is in a decline because the company is trying to buy Celgene Corporation CELG. Cramer is a big believer in Giovanni Caforio, the CEO of the company and he is a buyer of the stock.

Cramer is a buyer of Xilinx, Inc. XLNX because he sees it as the best 5G play.

W&T Offshore, Inc. WTI is a house of pain and Cramer would sell it. He thinks it's too dangerous.

Loading...
Loading...
BMY Logo
BMYBristol-Myers Squibb Co
$49.80-1.76%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
56.18
Growth
70.54
Quality
Not Available
Value
29.19
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Comments
Loading...